Recently, a pharmaceutical company came to the antibody-discovery specialist, Abveris, with a serious problem. The pharmaceutical company had tried and failed to develop a monoclonal antibody for an ...
In 2026, most companies are using AI in some fashion, as companies feel pressure to keep up with competitive industry dynamics and experiment with the new technology. The stocks on this list were ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results